News center_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

09-14

Immunoco-culture killing model from InnoModels Biotechnology

With the continuous development of oncology and immunology, finding more effective treatments has become a common goal for scientists and doctors. In this context, the PBMC-tumor cell co-culture killing platform, an immunoculture killing model launched by InnoModels Biotechnology (Beijing) Co., Ltd. has become an important breakthrough in immunocidal research in vitro. This innovative model not only provides researchers with an experimental platform that is closer to the physiological situation in vivo, but also brings new possibilities for the development and evaluation of immunotherapeutic drugs.

09-13

InnoModels Biotechnology qPCR Platform

In today's era of rapid biotechnology development, the research and development of oncology drugs are facing unprecedented challenges and opportunities. In order to more accurately assess drug effects, optimize drug structure and promote early drug release, scientists are constantly seeking more efficient and precise detection methods. InnoModels Biotechnology (Beijing) Co., Ltd. provides strong technical support for oncology drug research and development with its advanced qPCR (real-time quantitative polymerase chain reaction) platform.

09-12

Advantages of the InnoModels Biotechnology Inflammatory Bowel Disease (IBD) Model

Inflammatory Bowel Disease (IBD) is a group of complex, recurrent inflammatory diseases of the intestines, mainly including Crohn's Disease (CD) and Ulcerative Colitis (UC). As the incidence of IBD rises, the study of its pathogenesis and therapeutics becomes particularly important. Modeling organisms, especially mouse models, play a key role in this field. In this paper, we will introduce the advantages of InnoModels Biotechnology IBD models in detail.

09-11

Features of the Luminex platform from InnoModels Biotechnology

InnoModels Biotechnology (Beijing) Co., Ltd. is a high-tech enterprise founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion, and the Institute of Immunology of Shanghai Jiao Tong University. The company focuses on oncology and tumor immuno pharmacodynamics CRO services, translational medicine research services, and individualized medicine, and is committed to providing a new generation of experimental animal models close to the clinic for the research and development of oncology and tumor immunotherapy. One of the key technological highlights is the Luminex platform, which integrates Luminex's advanced bioassay technologies to provide researchers with efficient and accurate multi-assay solutions.

< 1...4 5 6...62 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License